Ernexa Therapeutics Inc.: Form DEF 14A, filed Apr 28, 2017
Filed with the SEC on Apr 28, 2017 and accepted by EDGAR at Apr 28, 2017, 16:30 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001493152-17-004542. Last ingested by Listed: Nov 6, 2026, 17:52 ET. Listed shows no prices and gives no investment advice.